Larvol Delta - Canadas-Drug-Agency-Issues-Final-Positive-Recommendation-Supporting-Public-Reimbursement-of-LEQEMBIR-lecanemab-for-Early-Alzheimers-Disease

Leqembi (lecanemab-irmb) - Biogen, Eisai

https://www.streetinsider.com/Press+Releases/Canadas+Drug+Agency+Issues+Final+Positive+Recommendation+Supporting+Public+Reimbursement+of+LEQEMBI%28R%29+%28lecanemab%29+for+Early+Alzheimers+Disease/27035211.html

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next